Related references
Note: Only part of the references are listed.Altered chromatin recruitment by FOXA1 mutations promotes androgen independence and prostate cancer progression
Bohan Xu et al.
CELL RESEARCH (2019)
Distinct structural classes of activating FOXA1 alterations in advanced prostate cancer
Abhijit Parolia et al.
NATURE (2019)
Clinical Development of Darolutamide: A Novel Androgen Receptor Antagonist for the Treatment of Prostate Cancer
Karim Fizazi et al.
CLINICAL GENITOURINARY CANCER (2018)
TXNDC9 promotes hepatocellular carcinoma progression by positive regulation of MYC-mediated transcriptional network
Dawei Chen et al.
CELL DEATH & DISEASE (2018)
Role of steroid receptor and coregulator mutations in hormone-dependent cancers
Anna C. Groner et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Thioredoxin-1 protects against androgen receptor-induced redox vulnerability in castration-resistant prostate cancer
Govindi J. Samaranayake et al.
NATURE COMMUNICATIONS (2017)
Tunicamycin induced endoplasmic reticulum stress promotes apoptosis of prostate cancer cells by activating mTORC1
Prasun Guha et al.
Oncotarget (2017)
PADI2-Mediated Citrullination Promotes Prostate Cancer Progression
Lin Wang et al.
CANCER RESEARCH (2017)
Interleukin-6-stimulated progranulin expression contributes to the malignancy of hepatocellular carcinoma cells by activating mTOR signaling
Feng Liu et al.
SCIENTIFIC REPORTS (2016)
The role of TXNDC5 in castration-resistant prostate cancer-involvement of androgen receptor signaling pathway
L. Wang et al.
ONCOGENE (2015)
Mitochondrial ROS in cancer: initiators, amplifiers or an Achilles' heel?
Simran S. Sabharwal et al.
NATURE REVIEWS CANCER (2014)
Mechanisms of Androgen Receptor Activation in Castration-Resistant Prostate Cancer
Nima Sharifi
ENDOCRINOLOGY (2013)
Targeted disruption of the p160 coactivator interface of androgen receptor (AR) selectively inhibits AR activity in both androgen-dependent and castration-resistant AR-expressing prostate cancer cells
Manjula Nakka et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2013)
Modulation of oxidative stress as an anticancer strategy
Chiara Gorrini et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
Oxidative stress and androgen receptor signaling in the development and progression of castration-resistant prostate cancer
Masaki Shiota et al.
FREE RADICAL BIOLOGY AND MEDICINE (2011)
Regulation of cancer cell metabolism
Rob A. Cairns et al.
NATURE REVIEWS CANCER (2011)
Optimisation of Conoidin A, a Peroxiredoxin Inhibitor
Gu Liu et al.
CHEMMEDCHEM (2010)
Castration resistance of prostate cancer cells caused by castration-induced oxidative stress through Twist1 and androgen receptor overexpression
M. Shiota et al.
ONCOGENE (2010)
Redox-Regulated Chaperones
Caroline Kumsta et al.
BIOCHEMISTRY (2009)
Antioxidant and oncogene rescue of metabolic defects caused by loss of matrix attachment
Zachary T. Schafer et al.
NATURE (2009)
Identification of conoidin A as a covalent inhibitor of peroxiredoxin II
Jeralyn D. Haraldsen et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2009)
Cooperative interactions between androgen receptor (AR) and heat-shock protein 27 facilitate AR transcriptional activity
Arnina Zoubeidi et al.
CANCER RESEARCH (2007)
Peroxiredoxin 1 interacts with androgen receptor and enhances its transactivation
Soo-Yeon Park et al.
CANCER RESEARCH (2007)
NF-κB activation by reactive oxygen species:: Fifteen years later
Geoffrey Gloire et al.
BIOCHEMICAL PHARMACOLOGY (2006)
Biology of progressive, castration-resistant prostate cancer: Directed therapies targeting the androgen-receptor signaling axis
HI Scher et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Molecular alterations in primary prostate cancer after androgen ablation therapy
CJM Best et al.
CLINICAL CANCER RESEARCH (2005)
Heat shock protein 90 (Hsp90) chaperone complex inhibitor, Radicicol, potentiated radiation-induced cell killing in a hormone-sensitive prostate cancer cell line through degradation of the androgen receptor
K Harashima et al.
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY (2005)
Two enzymes in one: Two yeast peroxiredoxins display oxidative stress-dependent switching from a peroxidase to a molecular chaperone function
HH Jang et al.
CELL (2004)
Redox regulation of PI 3-kinase signalling via inactivation of PTEN
NR Leslie et al.
EMBO JOURNAL (2003)
Androgenic regulation of oxidative stress in the rat prostate - Involvement of NAD(P)H oxidases and antioxidant defense machinery during prostatic involution and regrowth
NNC Tam et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Thioredoxins and related proteins in photosynthetic organisms: molecular basis for thiol dependent regulation
JP Jacquot et al.
BIOCHEMICAL PHARMACOLOGY (2002)
Phosphorylation-dependent ubiquitylation and degradation of androgen receptor by Akt require Mdm2 E3 ligase
HK Lin et al.
EMBO JOURNAL (2002)
Cellular response to oxidative stress: Signaling for suicide and survival
JL Martindale et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2002)
Studies on prostatic cancer - I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate
C Huggins et al.
JOURNAL OF UROLOGY (2002)
Peroxiredoxin, a novel family of peroxidases
SG Rhee et al.
IUBMB LIFE (2001)
Cross-talk between signal transducer and activator of transcription 3 and estrogen receptor signaling
T Yamamoto et al.
FEBS LETTERS (2000)
Thioredoxin, a putative oncogene product, is overexpressed in gastric carcinoma and associated with increased proliferation and increased cell survival
TM Grogan et al.
HUMAN PATHOLOGY (2000)
Share Paper
